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Available online 11 November 2015Chlamydiae are obligate intracellular bacteria developing in an intracytoplasmic niche, the inclusion. Chlamydia
growth measurement by inclusion counting is a key task in the development of novel antichlamydial antibiotics
and in vaccine studies. Most of the current counting methods rely on the immunoﬂuorescent staining of the
inclusions and eithermanual or automaticmicroscopy detection and enumeration. Themanual method is highly
labor intensive, while the automatic methods are either medium-throughput or require automatic microscopy.
The sensitive and speciﬁc PCR technology could be an effective method for growth related chlamydial DNA de-
tection; however the currently described PCR approaches have amajor limitation, the requirement of puriﬁcation
of DNA or RNA from the infected cells. This limitation makes this approach unfeasible for high-throughput
screenings. To overcome this, we developed a quantitative PCR (qPCR) method for the detection of Chlamydia
trachomatis DNA directly from the infected HeLa cells. With our method we were able to detect the bacterial
growth in a 4 log scale (multiplicity of infection (MOI): 64 to 0.0039), with high correlation between the biolog-
ical and technical replicates. As a further proof of themethod, we applied the direct qPCR for antibioticminimum
inhibitory concentration (MIC) measurements. The measured MICs of moxiﬂoxacin, tetracycline, clarithromycin
and compound PCC00213 were 0.031 μg/ml, 0.031 μg/ml, 0.0039 μg/ml and 6.2 μg/ml respectively, identical or
close to the already published MIC values. Our direct qPCR method for chlamydial growth and antibiotic MIC
determination is less time-consuming, more objective and more sensitive than the currently applied manual
or automatic ﬂuorescent microscopy- based methods.








Chlamydia trachomatis (C. trachomatis) ocular serovars A–C are re-
sponsible for acute and chronic inﬂammations of the conjunctiva and
urogenital serovars D–K are involved in acute and chronic urogenital
tract infections, while LGV serovars (L1–L3) cause lymphogranuloma
venereum, a chlamydial sexually transmitted disease (STD) with sys-
temic manifestations. The frequently chronic feature of these infections
could lead to debilitating consequences such as ectopic pregnancy,
infertility and blindness. C. trachomatis urogenital infections are the
most frequent bacterial STDs in theworld, with approximately 1.4million
infections yearly in the US (“CDC Sexually Transmitted Disease
Surveillance, 2013; http://www.cdc.gov/std/stats13/std-trends-508.
pdf,” n.d.). Approximately 10%–15% of untreated chlamydial infections
lead to pelvic inﬂammatory disease (PID), and about 10%–15% of PID
cases lead to infertility (Haggerty et al., 2010; Oakeshott et al., 2010).D.P. Virok).Trachoma, the progressive ﬁbrotic inﬂammation induced by
C. trachomatis ocular serovars, is the leading cause of preventable blind-
ness worldwide with 0.5 million people blind and 232 million people
being at risk of acquiring the disease (“WHO | Trachoma Fact sheet No
382, http://www.who.int/mediacentre/factsheets/fs382/en/,” 2014).
Azythromycin and doxycycline treatment of chlamydia infections is
considered to be effective, however treatment failures reached
15–19% in certain studies (Golden et al., 2005; Katz et al., 1998),
suggesting that novel antibiotics and/or antibiotics combinations
should be evaluated. An effective vaccine could prevent the sequelae
of chronic infections, however the effective vaccine targets and delivery
modes havenot yet been identiﬁed. Importantly, both the antibiotic and
vaccine research require the accurate and preferentially high dynamic
rangemeasurement of the decrease of C. trachomatis growth at different
time points and under various treatment regimens. Since the experi-
mental parameters combine in an exponential manner, the readout
method should be able to handle a large number of specimens in a
high-throughput way. The highly sensitive and speciﬁc PCR method
has been commonly used for the detection of C. trachomatis DNA in
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2015; Dhawan et al., 2014; Watson et al., 2002). The qPCR method
has also been used for the detection of the impact of different antibiotics
on the growth of C. trachomatis, measuring the DNA or RNA concentra-
tion as a readout. This technology accurately characterized the MICs of
oﬂoxacin, moxiﬂoxacin, azithromycin, doxycycline on C. trachomatis
(Peuchant et al., 2011a). In another study the doxycycline and
azithromycin MICs of the Chlamydia-related bacterium Waddlia
chondrophila have been characterized by qPCR (Goy and Greub, 2009).
The fundamental problem with these methods is that before the PCR
they require nucleic acid extraction from the infected cells, hence the
analysis of more than one or two dozen samples is not feasible. To
avoid column based DNA puriﬁcation, we developed a method where
we extract the DNA from the infected cells by two freeze–thaw cycles,
and perform a direct qPCR of the lysed cells. This streamlined protocol
needed signiﬁcantly less hands on time than the traditional qPCR and
proved to be highly sensitive. As a proof of principle, we were able to
detect the C. trachomatis growth over a 4 log concentration range and
accurately detect the C. trachomatis MICs of known and novel
antibiotics.
2. Materials and methods
2.1. Chlamydia strain propagation
C. trachomatis serovar D reference strain (UW-3/CX, ATCC)was used
in this study, and the chlamydia strain was propagated and partially
puriﬁed as described previously (Sabet et al., 1984).
2.2. Culture of HeLa cells, chlamydia infection and DNA extraction
HeLa 229 cells (ATCC) were transferred into the wells of the 96-well
plate (Sarstedt, Nümbrecht, Germany) at a density of 6 × 104 cells/well
in 100 μl of minimal essential medium (MEM) with Earle salts supple-
mented with 10% heat-inactivated fetal bovine serum (FBS), 2 mmol/l
L-glutamine, 1× non-essential amino acids, 8 mmol/l HEPES, 25 μg/ml
gentamycin. The cells were incubated for 1 h at room temperature
(RT) and then overnight at 37 °C, 5% CO2 to obtain a 90% conﬂuent cell
layer. For C. trachomatis infection, the wells were washed twice with
200 μl/well of phosphate buffered saline (PBS), pH 7.4. HeLa cells were
infected at various MOIs depending on the experiment. Inoculated
cells in 100 μl 0.5% (w/v) glucose medium were centrifuged at 800 g
for 60 min, RT. After infection, the cells were washed twice with PBS
and culture medium containing 1 μg/ml cycloheximide and 2-fold dilu-
tions of the respective antibiotics were added. The plates were incubat-
ed at 37 °C, 5% CO2 for 48 h. After the 48 h infection, the cells were
processed in 3 different ways: i, cell supernatants were used directly
as a template for qPCR ii, the cells with the supernatants were subjected
to 2× freeze–thaw cycles with a quick freezing (−80 °C, 15 min) and a
quick thawing on a plate shaker at RT. After the lysis, the cell lysates
were thoroughly mixed including the edges of the wells using a multi-
channel pipette. The mixed lysates were used as a template in the
qPCR iii, the supernatants of the cells were removed and the cells
were washed with PBS twice. After the second wash 100 μl Milli-Q
(MQ) water (Millipore, Billerica, MA, USA) was added to each well
and subjected to two freeze–thaw cycles and mixing as described
above. The mixed lysates were used as a template in the qPCR. All cell
culture reagentswere purchased fromSIGMA, St. Louis, MO, USA, unless
otherwise indicated.
2.3. Inhibition of chlamydia growth with antibiotics
Moxiﬂoxacin (Avelox; Bayer Pharma AG, Berlin, Germany), tetracy-
cline hydrochloride (SIGMA, St. Louis, MO, USA) and clarithromycin
(Klacid; Abbot, Chicago, IL, USA) were diluted in culture medium (see
above). Concentration ranges of 0.25–0.002 μg/ml for moxiﬂoxacin,tetracycline and clarithromycin with 2-fold dilutions were tested. The
stock solution of antibacterial drug candidate PCC00213 (10 mg/ml)
was prepared in dimethyl sulfoxide (DMSO) (SIGMA, St. Louis, MO,
USA) and further diluted in culture medium; the applied concentration
range was 50–0.391 μg/ml with 2-fold dilutions. After infection of HeLa
cells with C. trachomatis at a MOI 16, the culture medium with 1 μg/ml
cycloheximide was supplemented with the serial 2-fold dilutions of
the respective antibiotics and was added to triplicate wells. The cell
lysis/DNA extraction was performed according to the above described
iii, protocol.
2.4. Direct quantitative PCR
qPCR was performed using the Bio-Rad CFX96 real-time system. Ini-
tially both theMaxima SYBRGreenqPCRMasterMix (Thermo Scientiﬁc,
Waltham,MA, USA) and the SsoFast EvaGreenqPCR Supermix (Bio-Rad,
Hercules, CA, USA) master mixes were used, but after the performance
comparison the SsoFast EvaGreen qPCR supermix were used in the fur-
ther reactions. The qPCRs initially were performed with the
C. trachomatis 16S rRNA, ompA, ftsK, and pykF gene speciﬁc primer
pairs. The primer sequences were the following: 16S rRNA: 5′-CACA
AGCAGTGGAGCATGTGGTTT-3′, 5′-ACTAACGATAAGGGTTGCGCTCGT-
3′, ompA: 5′-TCGACGGAATTC TGTGGGAAGGTT-3′, 5′-TATCAGTTGTAG
GCTTGGCACCCA-3′, ftsK: 5′-AACTTGCAAGCTTCTAGCATCCGC-3′, 5′-
ATCACATCTCGAGAAGGGCGTTGT-3′, pykF: 5′-GTTGCCAACGCCATTTAC
GATGGA-3′, 5′-TGCATGTACAGGATGGGCTCCTAA-3′. After the sensitivi-
ty and speciﬁcity comparisons, the pykF primer pairs were chosen for
the further reactions. The PCR mixture consisted of 5 μl SsoFast
EvaGreen supermix, 1–1 μl forward and reverse primers (10 pmol
each), 1 μl template, and 2 μl MQ water to 10 μl ﬁnal volume. After the
10 min at 95 °C polymerase activation step, 40 PCR cycles of 20 s at 95
°C and 1 min at 64 °C were performed. The ﬂuorescence intensity was
measured at the end of the annealing-extension step. The speciﬁcity of
ampliﬁcation was conﬁrmed by melting curve analysis. For each PCR,
the cycle threshold (Ct) corresponding to the cyclewhere the ampliﬁca-
tion curve crossed the base line was determined. Student's t-test was
used to evaluate the statistical differences between the samples (3 bio-
logical replicates for each condition). For the statistical comparison both
the Ct values and the relative DNA concentration values were used. For
the relative DNA concentration calculation, the Ct data was normalized
so that the average measured C. trachomatis DNA concentration at the
highest applied antibiotic concentration was considered 1 and the rela-
tive DNA concentrations of the subsequent samples were compared to
this value using the 2–ΔΔCt formula.
2.5. DNA and RNA puriﬁcation by column puriﬁcation methods
To compare the detection sensitivity of the direct qPCR method and
the traditional nucleic acid extraction protocols, HeLa cells were cul-
tured in a 96 well plate, infected with C. trachomatis at MOI 64 and
MOI 1 and incubated for 48 h as described above. After the 48 h infec-
tion, the cells were processed in 4 differentways: i, the cells with the su-
pernatants were subjected to 2× freeze–thaw cycles and mixing as
described above ii, the supernatants of the cells were removed and the
cells were washed with PBS twice, and 100 μl MQ water was added to
the wells and subjected to two freeze–thaw cycles and mixing iii, the
cellular DNAwas extracted by a Quick-gDNAMiniPrep column puriﬁca-
tion kit (Zymo Research, Irvine, CA, USA) according to the
manufacturer's instructions, and eluted in 40 μl elution buffer iv, the cel-
lular RNA was extracted by a Quick-RNA MiniPrep column puriﬁcation
kit (ZymoResearch, Irvine, CA, USA) according to themanufacturer's in-
structions, and eluted in 40 μl nuclease-free buffer. 10 μl total RNA was
reverse transcribed by the qScript cDNA Synthesis Kit (Quanta
Biosciences, Gaithersburg, MD, USA) according to the manufacturer's
instructions. Before the qPCR the cDNA product was diluted with 40 μl
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primer pairs described above.
3. Results
3.1. Primer and master mix selection for direct qPCR
Four primer pairs targeting the ftsK, ompA, pykF genes and the 16S
rDNA region of the C. trachomatis genome were selected for further
evaluation. The template of the qPCR reactions were crude cell lysate
from HeLa cells infected with C. trachomatis (MOI 4) in a 96 well plate,
and lysed by two freeze–thaw cycles at 48 h post infection. The ideal
primer pairs should have detected the C. trachomatis DNA with high
sensitivity in a crude cell lysate template, but should not have bound
to and ampliﬁed the host genomic DNA, and should not have formed
primer–dimers. The four primer sequences were selected so that the
annealing-temperatures were close to 60 °C, enabling us to use a two-
step PCR. Ampliﬁcation plots (not shown) and melting curve analysis
(Fig. 1A–D) showed that all of the primers were able to detect the
C. trachomatisDNA. In the uninfected host cell lysate samples, the melt-
ing curve analysis showed that the ompA and especially the ftsK and 16S
rDNA primers ampliﬁed a 75–77 °C PCR product resembling primer–
dimer formation, and a 85–89 °C PCR product indicating aspeciﬁc ampli-
ﬁcation in the absence of the C. trachomatis DNA template. This was es-
pecially noticeable for the 16S rDNA. On the other hand, the pykF
primers showed absolutely no primer–dimer formation and aspeciﬁc
ampliﬁcation, indicating that the chance of misampliﬁcation will be
low even when the chlamydial DNA concentration is much lower than
the host's. To further test the speciﬁcity, we used the pykF primer
pairswithDNA from Escherichia coli, Enterococcus faecalis, Staphylococcus
aureus and Staphylococcus epidermidis. No ampliﬁcation was detected in
these qPCRs. Finally, the pykF primer pairs were tested in silico forFig 1. Primer selection for the direct qPCR. HeLa cells were infectedwith C. trachomatis, MOI 4. A
mixed and 1 μl of the lysate was used directly in a qPCR reaction using a 60 °C annealing temp
shown for the C. trachomatis speciﬁc primers ftsk (A), ompA (B), pykF (C) and 16S rDNA (D). The
bold lines show the melting temperature proﬁles of the uninfected cells.aspeciﬁc binding using the NCBI Primer-BLAST algorithm (Ye et al.,
2012) on the RefSeq genome database. No hits besides the various
C. trachomatis serovars were detected.
For the further qPCRs the pykF primer pairs were selected. The
optimal annealing temperatures of the pykF primers were screened
between 60 °C–72 °C by a gradient PCR.
Ampliﬁcation plots and melting curve analyses (Fig. 2A-B) showed
that the highest sensitivity was achieved when the annealing tempera-
ture was 64 °C. Finally, two qPCR master mixes containing either the
Sso7d fusion DNA polymerase or a regular Taq DNA polymerase
were compared for the optimal ampliﬁcation of the non-puriﬁed
C. trachomatis DNA template. Fig. 3 shows that the Sso7d fusion DNA
polymerase produced higher relative ﬂuorescent unit (RFU), and more
importantly approximately 2 cycles lower Ct (about 4 fold higher sensi-
tivity) than the TaqDNApolymerase. The Sso7d fusion DNApolymerase
was selected for further qPCRs.
3.2. Dynamic range of the direct qPCR
To measure the dynamic range of the qPCRmethod, HeLa cells were
infected with 1:2 serially diluted C. trachomatis ranging fromMOI 64 to
0.0039. DNA was extracted from the infected cells by two freeze–thaw
cycles at 48 h post infection, and 1 μl of the lysate was used directly
in a qPCR reaction. The qPCR method was able to detect the
C. trachomatis DNA quantitatively in all of the MOIs applied (Fig. 4).
The Ct values showed a high correlation (R2: 0.995)with the theoretical
Ct values through the whole 64–0.0039 (1/256) MOI range, indicating
that the direct qPCR method has a dynamic range of approximately
16,400 fold (64/0.0039). It has to be noted that the C. trachomatis DNA
could be detectedwhenwe used less than 0.0039MOI, but the Ct values
did not correlate well with the theoretical Ct values (data not shown);
MOIs over 64 were not tested.t 48 h post infection, DNAwas extracted from the infected cells by two freeze–thaw cycles,
erature and the SsoFast EvaGreen master mix (Bio-Rad). Melting temperature proﬁles are
thin lines show the qPCRmelting temperature proﬁles of C. trachomatis infected cells, the
Fig 2.Annealing temperature optimization of the pykF primers. HeLa cellswere infectedwith C. trachomatis, MOI 4. At 48 h post infection, DNAwas extracted from the infected cells by two
freeze–thaw cycles, mixed and 1 μl of the lysate was used directly in a qPCR reaction using various annealing temperatures (60 °C–72 °C), and the SsoFast EvaGreenmastermix (Bio-Rad).
Ampliﬁcation plots (A) andmelting temperature proﬁles (B) of the qPCR reactionswith various annealing temperatures are shown. The bold lines show the ampliﬁcation plot andmelting
temperature proﬁle of the qPCR reaction performed with an annealing temperature of 64 °C.
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nucleic acid extraction methods
In order to assess the detection sensitivity of the direct qPCR
method and the traditional nucleic acid extraction protocols, we in-
fected HeLa cells with C. trachomatis at MOI 64 and MOI 1 and incu-
bated for 48 h. At the end of the incubation, the cells were
processed in 4 different ways: i, the cells in their supernatants
were subjected to 2× freeze–thaw cycles ii, the cells were washed
with PBS twice, and MQ water was added to the wells before the
two freeze–thaw cycles iii, the cellular DNA was extracted by a col-
umn puriﬁcation method iv, the cellular RNA was extracted by a col-
umn puriﬁcation method and reverse transcribed (Fig. 5). For both
MOIs, the qPCR data showed that the lowest Ct-s (the highest sensi-
tivities) could be measured for the 16S rRNA expression, followed by
the direct lysis of the infected cells in MQwater, the column DNA pu-
riﬁcation method, the ompA gene expression and ﬁnally the direct
lysis of the infected cells in their media. The similar Ct standard devi-
ations indicated, that the reproducibilities of the different detection
methods were comparable.Fig 3. Performance comparison of the Sso7d fusion DNA polymerase and a regular Taq DN
moxiﬂoxacin (0.25 μg/ml–0.001 μg/ml). At 48 h post infection, infected cells were washed tw
was performed by two freeze–thaw cycles. After mixing the cell lysate, 1 μl of the lysate was us
mix (SsoFast EvaGreen Master Mix, Bio-Rad) or the Taq DNA polymerase master mix (Maxima
actionsperformedby the twomastermixes are shown. Insert shows the resulting−Ct values us
polymerase).3.4. Measurement of the sensitivity and technical reproducibility of the
direct qPCR in the presence of antibiotics
To assess the technical reproducibility of the direct qPCR, we in-
fected HeLa cells with C. trachomatis (MOI 16) in the presence of
1:2 dilutions of (A) moxiﬂoxacin and (B) tetracycline (Fig. 6 A–B).
At 48 h post infection, infected cells were either left unwashed in
the original medium or washed twice with PBS and ﬁnally 100 μl
MQ water was measured on the cells. The DNA extraction was per-
formed by two freeze–thaw cycles. Importantly, before the qPCR,
the lysates (~100 μl) were mixed 5–6 times with a multichannel pi-
pette (50 μl stroke volume) including the edges of the wells. qPCR re-
sulted in approximately 1.5–2 lower Ct value (2.8–4 fold higher
sensitivity) when the cells were washed and resuspended in MQ
water before lysis compared with the lysis in the original medium.
The further antibiotic growth inhibition measurements were per-
formed with washed cells. To assess the reproducibility of the direct
qPCR, 1 μl of the same lysate from one dilution series was measured
three times (Fig. 6 C–D). The Ct values demonstrated excellent
technical reproducibility in the case of both the moxiﬂoxacin andA polymerase. HeLa cells were infected with C. trachomatis, MOI 16 in the presence of
ice with PBS and ﬁnally 100 μl MQ water was measured on the cells. The DNA extraction
ed directly in a qPCR reaction containing either the Sso7d fusion DNA polymerase master
SYBR Green qPCRMaster Mix, Thermo Scientiﬁc). The ampliﬁcation plots of the qPCR re-
ing the twomastermixes (full circles: Sso7d fusionDNApolymerase, open circles: TaqDNA
Fig 4. Dynamic range measurement of the direct qPCR. HeLa cells were infected with 1:2
serially diluted C. trachomatis ranging from MOI 64 to 0.0039 (1/256). Each infection at a
particular MOI was performed in 3 parallel wells. At 48 h post infection, DNAwas extract-
ed from the infected cells by two freeze–thaw cycles,mixed and 1 μl of the lysatewas used
directly in a qPCR reaction. MOIs are shown as simple fractions instead of decimal num-
bers in order to follow the serial dilutions more easily. Data are means +/− standard de-
viations (SD) for the three parallel samples. The Pearson correlation coefﬁcient between
the theoretical and measured Ct values is also shown.
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among the three replicates ranged from 0.9921–0.9962 and 0.9980–
0.9992 in the case of moxiﬂoxacin and tetracycline inhibition experi-
ments, respectively. For the tested 8 moxiﬂoxacin and 8 tetracycline
samples, the standard deviations never exceeded the 2% of the average
of the 3 technical replicates.Fig 5. Comparison of C. trachomatis detection sensitivities using different nucleic acid ex-
traction methods. HeLa cells were infected with C. trachomatis, MOI 64 and MOI 1. At
48 h post infection, infected cells were either washed twice with PBS and ﬁnally 100 μl
MQwater wasmeasured on the cells or the cells were left unwashed. The DNA extraction
was performed by two freeze–thaw cycles. At 48 h post infection, DNAs from the infected
cellswere also puriﬁed by a columnpuriﬁcation protocol. At 48h post infection, total RNAs
from infected cells were puriﬁed by a column puriﬁcation protocol, reverse transcribed
and the expressions of the ompA gene and 16S rRNAweremeasured. In each case, the rel-
ative concentrations of chlamydial DNAs and cDNAs were detected by qPCR using either
the pykF primer pairs for the DNA samples, and the ompA and 16S rRNA primer pairs for
the RNA samples. MED: 2× freeze–thaw in medium, MQ: 2× freeze–thaw in MQ water,
DNA: DNA extracted by column puriﬁcation, ompA: ompA gene expression, 16S rRNA:
16S rRNA expression. *: Ct values are signiﬁcantly different (p b 0.05) from the MQ sam-
ples' using Student's t-test.3.5. C. trachomatis MIC value estimation of known and novel antibiotics by
direct qPCR
The direct qPCR method was used to determine the MIC of known
antichlamydial antibiotics moxiﬂoxacin, tetracycline and clarithromycin
and the novel antibiotic compound PCC00213. HeLa cells were infected
with C. trachomatis (MOI 16) in the presence of 1:2 dilutions of
moxiﬂoxacin (Fig. 7A), tetracycline (Fig. 7B), clarithromycin (Fig. 7C)
and compound PCC00213 (Fig. 7D) in 3 parallel wells. At 48 h post in-
fection, infected cells were washed twice with PBS and ﬁnally 100 μl
MQ water was measured on the cells. The DNA extraction was per-
formed by two freeze–thaw cycles. After mixing the cell lysate, 1 μl of
the lysate was used directly in a qPCR reaction. For MIC value estima-
tion, the chlamydial DNA concentrations (Ct values) measured in the
three parallel wells of a given antibiotic concentration were compared
with the Ct values measured in the three parallel wells of the highest
antibiotic concentration (we considered it as the inoculum) using
Student's t-test. The lowest antibiotic concentration, where the Ct
values did not change signiﬁcantly compared with the inoculum was
considered the MIC value. The moxiﬂoxacin MIC for C. trachomatis
was measured previously as 0.03–0.05 μg/ml (Peuchant et al., 2011a;
Donati et al., 1999; Shima et al., 2011; Bogdanov et al., 2014). The
qPCR showed that the last moxiﬂoxacin concentration that did not
change signiﬁcantly compared with the inoculum was 0.031 μg/ml.
The tetracycline MIC for C. trachomatis was characterized before as
0.03–0.15 μg/ml (Peuchant et al., 2011a; Ikeda-Dantsuji et al., 2011;
Welsh et al., 1992; Bogdanov et al., 2014). The qpCR showed that the
last tetracycline concentration that did not change signiﬁcantly com-
pared with the inoculum was 0.031 μg/ml. The clarithromycin MIC for
C. trachomatiswas characterized before as 0.0078–0.032 μg/ml (Samra
et al., 2001; Zheng et al., 2015). The qpCR showed that the last
clarithromycin concentration that did not change signiﬁcantly com-
pared with the inoculum was 0.0039 μg/ml. The compound PCC00213
MIC for C. trachomatis serovar D was characterized before as 6.25 μg/
ml (Bogdanov et al., 2014). The qpCR showed that the last PCC00213
concentration that did not change signiﬁcantly compared with the inoc-
ulum was 6.25 μg/ml.
4. Discussion
Manual counting of chlamydial inclusions requires excessive hands-
on time, technical skills, materials and equipments. Various alternative
methods have been developed to circumvent manual counting but
these methods are usually medium-throughput (Bogdanov et al., 2014),
have a limited dynamic range (Southern et al., 2012; Osaka and Hefty,
2013; Osaka et al., 2012; Bogdanov et al., 2014), aspeciﬁc (Osaka and
Hefty, 2013) or require expensive equipments, such as automated ﬂuo-
rescent microscope (Osaka et al., 2012). The limited dynamic range (~1
log) that is a feature ofmost of the currentmethods is especially a burden
when the viable Chlamydia count, the so-called recoverable IFU, is mea-
sured from infected cells or tissues. In this case several dilutions should
be prepared to determine the countable inclusion number, and each dilu-
tion counting should be performed in two–three parallels. As a practical
alternative, we developed a highly sensitive, streamlined method for the
detection of C. trachomatis growth, which only requires awidely available
qPCR machine. To circumvent the bottleneck of the qPCR method, the
DNA puriﬁcation, we used lysates of the infected cells as a template. To
achieve optimal qPCR performance using the unpuriﬁed DNA, we opti-
mized the major parameters of the reaction. Interestingly, the most obvi-
ous choice, the 16S rDNA primers showed primer dimer formation and
aspeciﬁc ampliﬁcation, which might be due to the aspeciﬁc binding to
human rDNA sequences and/or ampliﬁcation of bacterial DNA remnant
from the recombinant expression of the DNA polymerase. Since the
qPCR uses crude cell lysate as a template, the inhibition of the DNA poly-
merase could be a problem.We tested qPCRmastermixes with Taq poly-
merase and the Sso7d single stranded DNA binding protein fused DNA
Fig 6.Measurement of the sensitivity and technical reproducibility of the direct qPCR in antibiotic growth inhibition experiments. HeLa cells were infected with C. trachomatis, MOI 16 in
the presence of various concentrations of (A) tetracycline (0.25 μg/ml–0.002 μg/ml) and (B) moxiﬂoxacin (0.25 μg/ml–0.002 μg/ml). At 48 h post infection, infected cells were either
washed twicewith PBS and ﬁnally 100 μl MQwaterwasmeasured on the cells or the cellswere left unwashed. TheDNA extractionwas performed by two freeze–thaw cycles. Aftermixing
the cell lysate, 1 μl of the lysatewas used directly in a qPCR reaction. Representative of two experiments. (B) To assess the reproducibility of the qPCR, the same templates from the infected
and tetracycline (C) and moxiﬂoxacin (D) treated cells were measured three times using lysates from washed and MQ suspended cells. The Pearson correlation coefﬁcients calculated
among the three technical replicates are also shown.
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proximately 4 fold higher sensitivity. It has been described before, that
the fusionmakes the DNA polymerase highly efﬁcient and inhibitor resis-
tant, an ideal enzyme for direct qPCR (Wang et al., 2004). Nevertheless
the qPCR may be performed with Taq polymerase as well, especially
when the cells are washed before lysis. As a most easily available tem-
plate, we tested cell culture supernatant, and also crude cell lysate.
While the supernatant would be the simplest choice for direct qPCR, the
sensitivity using this template was 10–48 fold less than that using crude
cell lysate (data not shown). When we tested crude cell lysate we were
able to follow the chlamydial growth between MOI 64–0.039 (1/256)
with excellent correlation with the theoretical values, thus our method
may be ideal for measuring the recoverable IFU of chlamydia. It should
be noted that since the host cell number was relatively constant in our
experiments, in order to make the protocol the simplest we did not
normalize the pykF data with a host cell gene's. If the variable host cell
number is a major concern, normalization should be performed.
We compared various extraction and puriﬁcation methods to assess
the impact of potential PCR inhibitors in our crude cell lysate templates.
The results showed that the washed cells resuspended and lysed in MQ
water had 4–6 cycles lower Ct-s than the cells lysed in theirmedium, in-
dicating that the medium contained PCR inhibitors. Interestingly, cell
lysis in MQ water showed comparable sensitivity than the column
based DNA puriﬁcation. Possibly the column puriﬁcation removes the
remaining PCR inhibitors, but the relatively low cell number of a well
of a 96well plate is not optimal for this puriﬁcation. Peuchant et al. per-
formedMICmeasurements using puriﬁed total RNA from C. trachomatis
infected cells measuring chlamydial gene expression, including theompA and 16S rRNA (Peuchant et al., 2011b). When we compared our
MQ water method with the total RNA samples extracted by a column
based method, we concluded that our method was more sensitive
than the ompA gene expression measurement, but less sensitive than
the 16S rRNA. While the 16S rRNA expression had the highest sensitiv-
ity, thismethodwas themost labor-intensivewith RNA puriﬁcation and
reverse transcription, therefore it would be challenging tomake it high-
throughput. Also, it should be noted that certain chlamydial persistent
states maintains signiﬁcant RNA synthesis (Ouellette et al., 2006;
Belland et al., 2003), resulting a false-positive growth signal in the
RNAmeasurements. In these cases, chlamydial DNA levels better corre-
late to the chlamydial infectious units (Ouellette et al., 2006).
Since the direct qPCR could accurately follow chlamydial growth, we
assumed that it also could be easily applied for the growth reduction-
based MIC measurements. First, we investigated whether the presence
of antibiotics in the culture medium had an inhibitory effect on the
qPCR. We performed the DNA extraction with freeze–thaw cycles,
leaving the culture medium on the cells (crude cell lysate) or removing
it from the cells. The results showed that both methods could follow
the concentration dependent inhibitory effect of tetracycline and
moxiﬂoxacin, however, similarly to the previous extraction comparison
experiments, removal of the medium resulted in an approximately 4
fold higher sensitivity. The conclusion of the above mentioned sensitivity
comparisons is that, if someone wants a more streamlined protocol, then
the culture medium need not removed, however if a qPCR inhibition is
noted or expected, than removal of the culture medium, washing and
resuspending in MQ water is advisable before the freeze–thaw cycles.
We also tested the technical reproducibility of the direct qPCR in the
Fig 7.Measurement of MICs of known and novel antimicrobial compounds. HeLa cells were infectedwith C. trachomatis, MOI 16 in the presence of various concentrations of moxiﬂoxacin
(A), tetracycline (B), clarithromycin (C) and compound PCC00213 (D). Each infection at a particular antibiotic concentration was performed in 3 parallel wells. At 48 h post infection, in-
fected cellswerewashed twicewith PBS and ﬁnally 100 μl MQwaterwasmeasured on the cells. TheDNA extractionwas performed by two freeze–thaw cycles. Aftermixing the cell lysate,
1 μl of the lysate was used directly in a qPCR reaction. Data are the average−Ct values and the standard deviations. Inserts show linear qPCR data that was normalized so that the average
measured C. trachomatis DNA concentration at the highest applied antibiotic concentration was considered 1 and the relative DNA concentrations of the subsequent samples were com-
pared to this value using the 2−ΔΔCt formula. Data are means +/− standard deviations of the parallel samples. *: the relative DNA concentration values or the Ct values are signiﬁcantly
different (p b 0.05) from the values measured in the presence of the highest concentration of antibiotics using Student's t-test.
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reproducibility was high in both cases. Next, we characterized the MIC
values of three well-known and one novel antichlamydial antibiotics.
The determined MIC values were within what had already been pub-
lished ranges for tetracycline, moxiﬂoxacin and PCC00213, while the
clarithromycin MIC value was lower than had been published. Therefore
we characterized the MIC value using the immunoﬂuorescence based
ChlamyCount method (Bogdanov et al., 2014), and showed that the
clarithromycin MIC was indeed 0.0039 μg/ml for the particular
C. trachomatis strain we used (data not shown). Finding the MIC value
manually was simple for moxiﬂoxacin, but was less obvious for the
other three antibiotics, therefore we used a more robust approach. Ct
curves showed that the highest applied antibiotics concentration
inhibited completely the chlamydial growth, hence we considered this
chlamydial DNA as the DNA content of the inoculum. Afterwards, all the
Ct valuesmeasured in the three parallelwells of a given antibiotic concen-
tration were compared with the Ct values measured in the three parallel
wells of the highest antibiotic concentration using Student's t-test. The
MIC value was the lowest antibiotic concentration where the chlamydia
did not grow, or, in otherwords, the Ct values did not change signiﬁcantly
compared with the inoculum. Since there is a debate about how to calcu-
late signiﬁcant changes of qPCR data (Yuan et al., 2006), we used
Student's t-test on the Ct values and also on the linear values. Remarkably,
both calculations resulted in the same MIC values. Moreover, supporting
ourMIC calculation approach, all of the calculatedMICvalueswere similar
to the already published values, while the variant clarithromycin MIC
value was validated by an independent method.
We hope that our method will help to democratize chlamydial
growthmonitoring and encourage the research of novel antichlamydialcompounds and mechanisms. Also, the direct qPCR method can be ap-
plied for the growth screening of other intracellular pathogens.
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